NCT00860431View on ClinicalTrials.gov

Kremezin Study Against Renal Disease Progression in Korea

PHASE4CompletedINTERVENTIONAL
Enrollment

578

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Chronic Kidney Disease
Interventions
DRUG

AST-120

6g/day (3 times a day)

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

HK inno.N Corporation

INDUSTRY

collaborator

Kureha Corporation

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT00860431 - Kremezin Study Against Renal Disease Progression in Korea | Biotech Hunter | Biotech Hunter